Cutaneous squamous cell carcinoma in two pediatric lung transplant patients on prolonged voriconazole treatment. (10th July 2014)

• Record Type: Journal Article
• Authors: Wong, Jackson Y.; Kuzel, Paul; Mullen, John; Lien, Dale; Mahmood, Muhammad; Conrad, Carol; Fiorillo, Loretta
• Is Part Of: Pediatric transplantation. Volume 18:Number 6(2014:Sep.)
• Page Start: E200
• Page End: E207
• Publication Date: 2014-07-10
• Subjects: Transplantation of organs, tissues, etc. in children -- Periodicals; 617.95408305
• DOI: 10.1111/petr.12320
• Languages: English
• ISSNs: 1397-3142

Abstract

<abstract abstract-type="main" id="petr12320-abs-0001"> <title>Abstract</title> <p>Oral voriconazole is commonly used for treatment and prophylaxis of invasive fungal disease post‐LTx. Development of cutaneous SCC has been described in adult LTx recipients, although it is extremely rare in children. We describe two Caucasian children who developed cutaneous SCC beyond three yr post‐LTx. Both developed severe photosensitivity, actinic keratosis and required curative surgical excision of the cutaneous SCC lesions. Neither patient developed metastatic lesions nor had allograft dysfunction as a result of the SCC or the change in medical treatments. The effect of voriconazole on the development of malignant skin lesions is discussed and a recommendation on dermatologic surveillance, preventive measures against phototoxicity and early treatment of SCC are provided.</p> </abstract>